These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 19559353

  • 1. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
    Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M.
    Clin Imaging; 2009; 33(4):301-5. PubMed ID: 19559353
    [Abstract] [Full Text] [Related]

  • 2. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Tabatabaei S, Harisinghani M, McDougal WS.
    J Urol; 2005 Sep; 174(3):923-7; discussion 927. PubMed ID: 16093989
    [Abstract] [Full Text] [Related]

  • 3. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA, Saokar A, Harisinghani MG.
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA, Jager GJ, Hövels AM, de Hoop B, van den Bosch HC, Raat F, Witjes JA, Mulders PF, van der Kaa CH, Barentsz JO.
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [Abstract] [Full Text] [Related]

  • 5. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I.
    Gastric Cancer; 2006 May; 9(2):120-8. PubMed ID: 16767368
    [Abstract] [Full Text] [Related]

  • 6. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging.
    Saokar A, Braschi M, Harisinghani M.
    Abdom Imaging; 2006 May; 31(6):660-7. PubMed ID: 16680506
    [Abstract] [Full Text] [Related]

  • 7. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
    Pandharipande PV, Mora JT, Uppot RN, Goehler A, Braschi M, Halpern EF, Gazelle GS, Harisinghani MG.
    AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
    [Abstract] [Full Text] [Related]

  • 8. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I.
    J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
    [Abstract] [Full Text] [Related]

  • 9. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
    Barentsz JO, Fütterer JJ, Takahashi S.
    Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
    [Abstract] [Full Text] [Related]

  • 10. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Montie JE.
    J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers.
    Saksena M, Harisinghani M, Hahn P, Kim J, Saokar A, King B, Weissleder R.
    AJR Am J Roentgenol; 2006 Dec; 187(6):W582-8. PubMed ID: 17114509
    [Abstract] [Full Text] [Related]

  • 12. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
    Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R.
    AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
    [Abstract] [Full Text] [Related]

  • 13. Re: Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Kroon BK, Horenblas S.
    J Urol; 2006 Mar; 175(3 Pt 1):1174. PubMed ID: 16469648
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overview of nanoparticle use in cancer imaging.
    Islam T, Harisinghani MG.
    Cancer Biomark; 2009 Mar; 5(2):61-7. PubMed ID: 19414922
    [Abstract] [Full Text] [Related]

  • 16. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
    Dinniwell R, Chan P, Czarnota G, Haider MA, Jhaveri K, Jewett M, Fyles A, Jaffray D, Milosevic M.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):844-51. PubMed ID: 19095369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10.
    Saokar A, Gee MS, Islam T, Mueller PR, Harisinghani MG.
    Clin Imaging; 2010 Jul 01; 34(6):448-52. PubMed ID: 21092874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.